Vladislava Juric
Overview
Explore the profile of Vladislava Juric including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Juric V, Mayes E, Binnewies M, Lee T, Canaday P, Pollack J, et al.
Sci Transl Med
. 2023 Aug;
15(711):eadd9990.
PMID: 37647386
Myeloid cells in the tumor microenvironment (TME) can exist in immunosuppressive and immunostimulatory states that impede or promote antitumor immunity, respectively. Blocking suppressive myeloid cells or increasing stimulatory cells to...
2.
Binnewies M, Pollack J, Rudolph J, Dash S, Abushawish M, Lee T, et al.
Cell Rep
. 2021 Oct;
37(3):109844.
PMID: 34686340
Converting checkpoint inhibitor (CPI)-resistant individuals to being responsive requires identifying suppressive mechanisms. We identify TREM2 tumor-associated macrophages (TAMs) as being correlated with exhausted CD8 tumor-infiltrating lymphocytes (TILs) in mouse syngeneic...
3.
Juric V, Ruffell B, Evason K, Hu J, Che L, Wang L, et al.
J Hepatol
. 2015 Dec;
64(4):881-90.
PMID: 26639397
Background & Aims: The leukocyte composition of tumors is heterogeneous, as is the involvement of each leukocyte subset in promoting or restraining tumorigenesis. This heterogeneity reflects the tissue of origin,...
4.
Evason K, Francisco M, Juric V, Balakrishnan S, Lopez Pazmino M, Gordan J, et al.
PLoS Genet
. 2015 Jul;
11(7):e1005305.
PMID: 26134322
Hepatocellular carcinoma (HCC) is one of the most lethal human cancers. The search for targeted treatments has been hampered by the lack of relevant animal models for the genetically diverse...
5.
Juric V, Chen C, Lau L
PLoS One
. 2012 Feb;
7(2):e31303.
PMID: 22363611
Although TNFα is a strong inducer of apoptosis, its cytotoxicity in most normal cells in vitro requires blockade of NFκB signaling or inhibition of de novo protein synthesis, typically by...
6.
Chen C, Juric V, Lau L
Adv Exp Med Biol
. 2010 Dec;
691:595-603.
PMID: 21153366
No abstract available.
7.
Franzen C, Chen C, Todorovic V, Juric V, Monzon R, Lau L
Mol Cancer Res
. 2009 Jul;
7(7):1045-55.
PMID: 19584265
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) plays an important role in immune surveillance and preferentially induces apoptosis in cancer cells over normal cells, suggesting its potential in cancer therapy. However,...
8.
Juric V, Chen C, Lau L
Mol Cell Biol
. 2009 Apr;
29(12):3266-79.
PMID: 19364818
Although Fas ligand (FasL) is primarily expressed by lymphoid cells, its receptor Fas (CD95/Apo-1) is broadly expressed in numerous nonlymphoid tissues and can mediate apoptosis of parenchymal cells upon injury...
9.
Leu S, Chen N, Chen C, Todorovic V, Bai T, Juric V, et al.
J Biol Chem
. 2004 Aug;
279(42):44177-87.
PMID: 15322081
The matricellular protein CCN1 (CYR61) regulates multiple cellular processes and plays essential roles in embryonic vascular development. A ligand of several integrin receptors, CCN1 acts through integrin alpha6beta1 and heparan...
10.
Djarmati A, Hedrich K, Svetel M, Schafer N, Juric V, Vukosavic S, et al.
Hum Mutat
. 2004 Apr;
23(5):525.
PMID: 15108293
Mutations in the Parkin (PARK2) and the DJ1 (PARK7) gene cause early-onset Parkinson disease (EOPD). We tested 75 Serbian EOPD patients for mutations in both genes by conventional mutational screening...